Vivek Reddy, MD
Clinical Cardiac Electrophysiology · Kankakee, ILNPI 1396131835
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (57.4%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Medtronic at 54.7% of the total. Reporting peaked in 2021 at $15,715 and has fallen 94.5% since, to $859 in 2025.
Across 200 payments — averaging $174.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$19K
- Boston Scientific$11K
- Medical Device Business Services, Inc.$2K
- Biosense Webster, Inc.$1K
- Abbott$324
- Novartis$239
- plus $1K from 23 others
Across 1 payment — averaging $98,348 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Cortex, Inc.$98K
What the payments were for
- Grants$20,00057%
- Travel & lodging$7,08420%
- Food & beverage$7,08220%
- Education$6732%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 102 | $19,069 |
| Boston Scientific | 12 | $10,758 |
| Medical Device Business Services, Inc. | 7 | $1,863 |
| Biosense Webster, Inc. | 12 | $1,202 |
| Abbott | 2 | $324 |
| Novartis | 4 | $239 |
| Pfizer | 11 | $168 |
| E.r. Squibb & Sons, L.L.C. | 9 | $139 |
| Johnson & Johnson | 2 | $130 |
| Atricure, Inc. | 2 | $102 |
| Amgen | 6 | $101 |
| Cortex, Inc. | 1 | $93 |
| AstraZeneca | 1 | $88 |
| Boehringer Ingelheim | 4 | $85 |
| Alnylam Pharmaceuticals Inc. | 3 | $76 |
| Novo Nordisk | 3 | $52 |
| Esperion Therapeutics, Inc. | 2 | $39 |
| Chiesi USA, Inc. | 2 | $38 |
| Philips North America LLC | 1 | $37 |
| Elutia, Inc. | 2 | $36 |
| Lantheus Medical Imaging, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $24 |
| Scpharmaceuticals Inc. | 1 | $23 |
| Akcea Therapeutics, Inc. | 1 | $23 |
| Edwards Lifesciences | 1 | $21 |
| Merck | 1 | $15 |
| Actelion Pharmaceuticals US, Inc. | 1 | $15 |
| Cardiovascular Systems Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EMBLEM S ICD ELECTRODE DELIVERY SYSTEM$5,000
- EMBLEM MRI S-ICD$5,000
- Carto 3$2,830
- Micra$898
- COBALT DR MRI SURESCAN$507
- Adapta$318
- EnSite Precision Cardiac Mapping System$183
- WATCHMAN FLX$150
- QDOT MICRO Catheter$144
- Ensite Cardiac Mapping System$142
- Solitaire$137
- S-ICD System Magnet$118
- XARELTO$115
- LEQVIO$112
How this compares
$34,839 in reported general payments places this provider in the 55th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
See all clinical cardiac electrophysiology providers in Illinois →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 77 | $91,438 |
| XareltoRivaroxaban | 17 | $14,573 |
| Dofetilide | 36 | $11,629 |
| Metoprolol Succinate | 114 | $1,516 |
| Amiodarone Hcl | 63 | $1,034 |
| Metoprolol Tartrate | 20 | $920 |
| SotalolSotalol Hcl | 43 | $761 |
| Carvedilol | 23 | $264 |
| Spironolactone | 28 | $241 |
| Losartan Potassium | 15 | $218 |
| Doxycycline Monohydrate | 32 | $185 |
| Doxycycline Hyclate | 19 | $176 |
| Pantoprazole Sodium | 15 | $123 |
| Furosemide | 16 | $87 |
| ClopidogrelClopidogrel Bisulfate | 11 | $80 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $168 | $91,43877 claims |
| Johnson & JohnsonXarelto | $130 | $14,57317 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 158 clinical cardiac electrophysiology providers in Illinois.
Other clinical cardiac electrophysiology in Kankakee
- Mansour RazminiaPalos Heights$927K
- Mark MetzlEvanston$799K
- Roderick TungChicago$795K
- Bradley KnightChicago$661K
- Gaurav UpadhyayChicago$593K
- Henry HuangGeneva$501K
- Kousik KrishnanNaperville$311K
- Hany DemoChicago$297K
- Cash CaseyElmhurst$287K
- Moeen SaleemNaperville$249K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.